Articles

Medical Foods by: Lisa King

2020-06-04T09:21:58-07:00June 4th, 2020|Articles|

An Introductory Guide to Medical Foods    Hippocrates, “The Father of Medicine” stated “Let food be thy medicine and medicine be thy food.”  The benefits of food as medicine have been known for years.  However, did you know that there are medical foods that can be dispensed in a pharmacy setting?    Medical foods are foods that [...]

Patient Access To Care – MyDrCares + AlphaScrip

2020-02-18T14:33:54-07:00February 18th, 2020|Articles|

Excited to be working with MyDrCares and successful entrepreneurs Jay and Anne-Sophie Whitehead in providing sponsor funded continuum of care for local patients in need.   Leveraging our Visa/MasterCard debit card platform,  MyDrCares will help in removing cost as an impediment to the necessary care patients in local communities need.  Funds loaded onto the MyDrCares [...]

How to Market Reformulated Pharmaceuticals

2019-03-12T12:33:42-07:00March 20th, 2018|Articles|

There are different reasons as to why a pharmaceutical company might choose to reformulate an existing drug product. Doing so is an vital part of stretching their drug’s lifecycle management strategy within a cost-constrained environment. It is faster and less expensive to bring a reformulated drug to market than a new compound. Drug reformulations generally focus [...]

Maximize Profits Before Loss of Exclusivity

2018-03-06T12:24:26-07:00March 6th, 2018|Articles|

The expiration of drug patents causes financial challenges for most pharmaceutical companies. Considering that it is common for drugs to take up to eight years for FDA approval, that leaves only 12 years on the market before patents expire and less expensive, generic versions hit the market. The Patent Cliff The patent cliff refers to [...]

Analytics for Pharmaceutical Sales

2019-03-28T16:21:30-07:00February 20th, 2018|Articles|

In the age of analytics, there's no shortage of data collection. The goal then becomes using intelligent systems to make sound, data-driven business decisions. The ability to accurately predict cause and effect through data, obtained through advanced client reporting systems, can help pharmaceutical companies make better business decisions. What Type of Data Should Pharmaceutical Companies [...]

Using Starter Samples to Increase Prescriptions

2018-02-06T10:34:19-07:00February 6th, 2018|Articles|

It used to be common for pharmaceutical representatives to provide samples of medications for physicians to give to their patients. However, AlphaScrip offers a better alternative to traditional sampling methods through their pharmaceutical service program-- sample vouchers. What is a Sample Voucher?  When participating in the sample voucher program, a physician will give his or her patient [...]

How to Increase Patient Compliance

2019-03-28T16:23:02-07:00January 16th, 2018|Articles|

Miracles of modern medicine have been made possible through the development of prescription drugs that help cure, or at least manage, the symptoms of serious diseases and chronic conditions. However, if patient compliance is lacking, such as failing to regularly fill prescriptions, delaying refills, or going off their medications, patients are not receiving the full [...]

Guide to Pharma Patents

2018-01-02T10:04:55-07:00January 2nd, 2018|Articles|

In the United States, patents are commonly issued for twenty years. This includes patents that are obtained by pharmaceutical companies for new drugs. However, because companies apply for patents before clinical trials begin to test the safety and efficacy of drugs, the effective patent period is often between seven to twelve years after FDA approval. What [...]

Should Pharmacists Be More Involved in Patient Care?

2017-12-19T13:37:21-07:00December 19th, 2017|Articles|

The answer would be yes, according to a recent study from the Johns Hopkins Center for Health Services that was funded by the National Association of Chain Drug Stores (NACDS). As budgets are in decline for public health resources, pharmacies can be leveraged as a community resource to advance community-based health priorities. Teaming up pharmacists [...]

New Biosimilar Cancer Drugs Approved

2017-12-05T13:32:11-07:00December 5th, 2017|Articles|

Cancer patients are expected to benefit from the recent approval by the FDA of the first biosimilar drug to treat various types of cancer. This drug, bevacizumab-awwb, known as Myasi, is the biosimilar of bevacizumab, known as Avastin. While the FDA has approved the use of Myasi as a biosimilar, it is not approved as [...]